Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

SBC Medical Group Holdings (SBC) Accumulated Depreciation & Amortization (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Accumulated Depreciation & Amortization readings, the most recent being $9.1 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 18.72% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.1 million, a 18.72% decrease, with the full-year FY2025 number at $9.1 million, down 18.72% from a year prior.
  • Accumulated Depreciation & Amortization hit $9.1 million in Q4 2025 for SBC Medical Group Holdings, down from $11.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $12.9 million in Q2 2025 to a low of $9.1 million in Q4 2025.
  • Median Accumulated Depreciation & Amortization over the past 3 years was $11.2 million (2024), compared with a mean of $11.4 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 5.76% in 2024 and later fell 18.72% in 2025.
  • SBC Medical Group Holdings' Accumulated Depreciation & Amortization stood at $10.6 million in 2023, then grew by 5.76% to $11.2 million in 2024, then dropped by 18.72% to $9.1 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $9.1 million (Q4 2025), $11.0 million (Q3 2025), and $12.9 million (Q2 2025) per Business Quant data.